Cite
Ghelli Luserna Di Rorà A, Ghetti M, Ledda L, et al. Exploring the ATR-CHK1 pathway in the response of doxorubicin-induced DNA damages in acute lymphoblastic leukemia cells. Cell Biol Toxicol. 2021;doi: 10.1007/s10565-021-09640-x.
Ghelli Luserna Di Rorà, A., Ghetti, M., Ledda, L., Ferrari, A., Bocconcelli, M., Padella, A., Napolitano, R., Fontana, M. C., Liverani, C., Imbrogno, E., Bochicchio, M. T., Paganelli, M., Robustelli, V., Sanogo, S., Cerchione, C., Fumagalli, M., Rondoni, M., Imovilli, A., Musuraca, G., Martinelli, G., & Simonetti, G. (2021). Exploring the ATR-CHK1 pathway in the response of doxorubicin-induced DNA damages in acute lymphoblastic leukemia cells. Cell biology and toxicology, . https://doi.org/10.1007/s10565-021-09640-x
Ghelli Luserna Di Rorà, Andrea, et al. "Exploring the ATR-CHK1 pathway in the response of doxorubicin-induced DNA damages in acute lymphoblastic leukemia cells." Cell biology and toxicology vol. (2021). doi: https://doi.org/10.1007/s10565-021-09640-x
Ghelli Luserna Di Rorà A, Ghetti M, Ledda L, Ferrari A, Bocconcelli M, Padella A, Napolitano R, Fontana MC, Liverani C, Imbrogno E, Bochicchio MT, Paganelli M, Robustelli V, Sanogo S, Cerchione C, Fumagalli M, Rondoni M, Imovilli A, Musuraca G, Martinelli G, Simonetti G. Exploring the ATR-CHK1 pathway in the response of doxorubicin-induced DNA damages in acute lymphoblastic leukemia cells. Cell Biol Toxicol. 2021 Sep 14; doi: 10.1007/s10565-021-09640-x. Epub 2021 Sep 14. PMID: 34519926.
Copy
Download .nbib